Ojas Mainkar
Pain Medicine · New Britain, CTNPI 1689108110
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Boston Scientific at 52.4% of the total. Reporting peaked in 2023 at $3,140 and has fallen 86.0% since, to $439 in 2025.
Across 37 payments — averaging $119.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Pacira Pharmaceuticals Incorporated$925
- Vertos Medical, Inc.$321
- Saluda Medical Americas, Inc.$197
- SPR Therapeutics, Inc$197
- Nevro Corp.$135
- plus $330 from 7 others
What the payments were for
- Travel & lodging$2,59259%
- Food & beverage$1,83141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $2,317 |
| Pacira Pharmaceuticals Incorporated | 7 | $925 |
| Vertos Medical, Inc. | 4 | $321 |
| Saluda Medical Americas, Inc. | 3 | $197 |
| SPR Therapeutics, Inc | 5 | $197 |
| Nevro Corp. | 1 | $135 |
| Vertex | 1 | $116 |
| Si-bone, Inc. | 1 | $93 |
| Orthofix Medical, Inc. | 1 | $38 |
| Stryker | 1 | $34 |
| Coastal Technology Solutions LLC | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| BD | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$846
- Evoke$177
- Senza$135
- mild Device Kit$128
- JOURNAVX$116
How this compares
$4,422 in reported general payments places this provider in the 65th percentile of 69 pain medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 13 | $5,082 |
| OxycontinOxycodone Hcl | 16 | $5,003 |
| Duloxetine Hcl | 185 | $4,935 |
| Pregabalin | 134 | $3,964 |
| Gabapentin | 295 | $3,378 |
| Lidocaine | 43 | $2,543 |
| Tizanidine Hcl | 97 | $2,043 |
| Methocarbamol | 85 | $1,581 |
| Oxycodone Hcl | 83 | $927 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $799 |
| Fentanyl | 12 | $732 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $646 |
| Cyclobenzaprine Hcl | 63 | $574 |
| Baclofen | 12 | $458 |
| Tramadol Hcl | 50 | $429 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in New Britain
- Jeffrey BegleiterNew Britain$671
- Sandeep JoharWaterbury$329K
- David GutierrezNew Haven$151K
- Brian GrosbergWest Hartford$99K
- Ofer WellischStamford$18K
- Yili HuangNew Haven$18K
- Jared RosenbergGreenwich$12K
- Sandhya MehlaWest Hartford$12K
- Hans KnoppMiddlebury$11K
- Daniel HaddadNew Haven$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.